HLA-DQB1 antibody (AA 128-175)
-
- Target See all HLA-DQB1 Antibodies
- HLA-DQB1 (Major Histocompatibility Complex, Class II, DQ beta 1 (HLA-DQB1))
-
Binding Specificity
- AA 128-175
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This HLA-DQB1 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Cross-Reactivity
- Human, Mouse
- Purification
- >95%, Protein G purified
- Immunogen
- Recombinant Human HLA class II histocompatibility antigen, DQ beta 1 chain protein (128-175AA)
- Isotype
- IgG
-
anti-Major Histocompatibility Complex, Class II, DQ beta 1 (HLA-DQB1) (AA 1-261) antibody
HLA-DQB1 Reactivity: Human WB, FACS Host: Mouse Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class II, DQ beta 1 (HLA-DQB1) (AA 13-39), (N-Term) antibodyHLA-DQB1 Reactivity: Human WB Host: Rabbit Polyclonal unconjugated
anti-Major Histocompatibility Complex, Class II, DQ beta 1 (HLA-DQB1) (AA 129-217) antibodyHLA-DQB1 Reactivity: Human WB, ELISA Host: Mouse Monoclonal 1G6 unconjugated
anti-Major Histocompatibility Complex, Class II, DQ beta 1 (HLA-DQB1) (AA 1-261) antibodyHLA-DQB1 Reactivity: Human IP Host: Rabbit Polyclonal unconjugated
-
- Application Notes
- Recommended dilution: WB:1:200-1:3000, IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- HLA-DQB1 (Major Histocompatibility Complex, Class II, DQ beta 1 (HLA-DQB1))
- Alternative Name
- HLA-DQB1 (HLA-DQB1 Products)
- Synonyms
- CELIAC1 antibody, HLA-DQB antibody, IDDM1 antibody, mhc-DRB antibody, DLA-DQB antibody, MAMU-DQB1 antibody, LOC100172120 antibody, DKFZp469C0237 antibody, major histocompatibility complex, class II, DQ beta 1 antibody, HLA-DQB1 antibody, PATR-DQB1 antibody, DLA-DQB1 antibody, MAMU-DQB1 antibody, LOC100172120 antibody
- Background
-
Background: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading.
Aliases: CELIAC1 antibody, DQ beta 1 chain antibody, DQB1_HUMAN antibody, HLA class II histocompatibility antigen antibody, HLA class II histocompatibility antigen, DQ beta 1 chain antibody, HLA class II histocompatibility antigen, DQ beta 2 chain antibody, HLA DQB antibody, HLA DQB1 antibody, HLA-DQB1 antibody, HLA-DQB2 antibody, IDDM1 antibody, Lymphocyte antigen antibody, Major histocompatibility complex class II beta antibody, Major histocompatibility complex, class II, DQ beta 1 antibody, MHC class II antigen DQB1 antibody, MHC class II antigen HLA DQ beta 1 antibody, MHC class II DQ beta chain antibody, MHC class II HLA DQ beta glycoprotein antibody, MHC class2 antigen antibody, MHC DQ beta antibody, OTTHUMP00000029167 antibody, OTTHUMP00000178569 antibody, OTTHUMP00000178570 antibody, OTTHUMP00000178571 antibody
- UniProt
- P01920
- Pathways
- TCR Signaling, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-
